Disposable Arterial Blood Sampling Kits Market Size is predicted to exhibit a 7.56% CAGR during the forecast period for 2024-2031.
The rapid surge in demand for safe blood collection devices stands as a significant factor driving the growth and demand for arterial blood collection in the market. Moreover, the escalating population of aging individuals afflicted with chronic diseases, along with the heightened need for diagnosing such conditions, further fuels the expansion of the global market in the forecasted period. Adherence to regulatory standards and guidelines not only enhances the quality and reliability of products but also fosters trust among healthcare providers, thereby propelling market growth. Point-of-care testing (POCT) facilitates swift diagnostic procedures at or near the patient's location, delivering immediate results crucial for informed clinical decision-making.
Moreover, disposable arterial blood sampling kits play a pivotal role in POCT by enabling rapid and convenient blood sample collection, thereby witnessing increased adoption across various healthcare settings. Additionally, the growing preference for robotic surgery, combined with limited awareness and high costs associated with automated blood collection devices may hinder the expansion of the arterial blood collection market. Similarly, challenges related to storage, transportation, and a shortage of skilled professionals could also impede its growth potential.
Competitive Landscape
Some Major Key Players In The Disposable Arterial Blood Sampling Kits Market:
- Siemens Healthcare Private Limited
- Becton, Dickinson and Company
- Lepus Medical Technology (Beijing)Co. Ltd.
- Cardinal Health
- SPM Medicare Pvt. Ltd
- Lev ram Lifesciences Pvt. Ltd.
- ICU Medical
- Radiometer Company
- Thermos Fisher Scientific Inc.
- Vyaire Medical Inc.
- Other Prominent Players
Market Segmentation:
The disposable arterial blood sampling kits market is segmented as product type and end-user. Based on the product, the disposable arterial blood sampling market is segmented as 1 ml (syringe volume) and 3 mL (syringe volume). By end-user, the disposable arterial blood sampling market is segmented into hospitals, clinics, and others.
Based On Product, The 3ml Segment Is Accounted As A Major Contributor In The Disposable Arterial Blood Sampling Kits Market.
The 3 mL syringe volume segment emerges as the leading force in the worldwide market for disposable arterial blood sampling kits, propelled by a multitude of factors. This particular size strikes an ideal balance between precision and practicality, offering an optimal sample volume for accurate diagnostics. Its dominance stems from several key factors, including its alignment with healthcare standards, compatibility with sampling devices, and cost-effectiveness. Renowned for its versatility, the 3 mL size caters to a wide array of diagnostic applications and is favored for its ease of handling and storage. Furthermore, physician preferences, training protocols, and market demand contribute to bolstering its position as the preferred choice. Success within this segment is further influenced by adherence to industry standards, supplier practices, and alignment with evolving market requirements.
The Hospital Category Is Growing At A Rapid Rate.
The hospital category is projected to grow at a rapid rate in the global disposable arterial blood sampling kits market. Hospitals are at the forefront of the global market for disposable arteria blood sampling kits due to several factors. Their large patient volumes and diverse range of medical specialties necessitate a constant need for these kits. Especially crucial in emergency and critical care scenarios, these offer rapid and infection-controlled solutions. Hospitals' stringent infection control protocols are well-suited to the single-use design of disposable kits, ensuring patient safety. Moreover, centralized diagnostic laboratories within hospitals find the convenience and sterility of disposable kits highly beneficial. Factors such as the need for regular monitoring, integration of technology, compliance with regulations, and the potential for cost savings through bulk purchases all contribute to hospitals' predominant role in adopting disposable arterial blood sampling kits.
In The Region, The North American Disposable Arterial Blood Sampling Kits Market Has A Significant Revenue Share.
The North American Disposable Arterial Blood Sampling Kits market is expected to mark the highest market revenue share in the near future. The North American market is subject to stringent regulatory requirements by agencies such as the FDA (Food and Drug Administration) in the United States and Health Canada. Reimbursement policies and coverage for medical devices vary across states and provinces within North America, impacting the adoption and utilization of disposable arterial blood sampling kits. Manufacturers need to navigate these reimbursement complexities to ensure market access and PR duct uptake.
In addition, the Asia Pacific regional market is projected to develop at a speedy rate in the global Disposable Arterial Blood Sampling Kits market. The APAC region is experiencing tremendous growth in healthcare infrastructure and expenditure, driven by rising populations, increasing chronic diseases, and improving access to healthcare services. This growth fuels demand for disposable arterial blood sampling kits as they are essential for various diagnostic and monitoring procedures.
Recent Developments:
- In May 2022, The strategic partnership between Babson Diagnostics and Becton, Dickinson and Company (BD) was extended in order to facilitate the collection of blood samples in additional care settings. This entailed delegating the collection of blood samples for diagnostic testing to patients' residences. In 2019, the organizations formed a collaborative effort to create a capillary blood collection and testing system that would enable inexperienced team members to perform lab-quality, low-volume capillary blood collection in retail environments.
Disposable Arterial Blood Sampling Kits Market Report Scope
|
Report Attribute |
Specifications |
|
Growth Rate CAGR |
CAGR of 7.56 % from 2024 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Million and CAGR from 2024 to 2031 |
|
Historic Year |
2019 to 2023 |
|
Forecast Year |
2024-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Product Type And End-User |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South East Asia; South Korea |
|
Competitive Landscape |
Siemens Healthcare Private Limited, Becton Dickinson and Company, and Lepus Medical Technology. Cardinal Health SPM Medicare Pvt. Ltd, Lev ram Lifesciences Pvt. Ltd., ICU Medical, Radiometer Company, Thermos Fisher Scientific Inc. and Vyaire Medical Inc. |
|
Customization Scope |
Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Corporate
Office :
Office No.5170, 5th Floor Marvel Fuego, Magarpatta Rd, Pune, 411028
info@insightaceanalytic.com
